Related Experiment Videos
Evaluation of the effect of pharmacologic agents on crush-avulsion arterial injuries: a scanning electron microscopy
F H Savoie1, B C Cooley, J S Gould
1Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee 53226.
Abstract:
This study was designed to investigate the short-term formation and composition of thrombus occurring at sites of arterial intimal injury in rabbits. Anti-coagulants, platelet anti-aggregation agents, and fibrinolytic agents were evaluated for their influence upon the developing thrombus, utilizing scanning electron microscopy to determine thrombus surface composition. These agents included: heparin, aspirin, dextran 40, streptokinase, and prostacyclin. The results are consistent with the known nature of each of these agents. When two agents were given simultaneously, each acting on different aspects of thrombogenesis (platelets vs. fibrin), the outcome appeared synergistic, with substantial reduction in thrombus accumulation; clear inhibition of both platelet aggregation and fibrin polymerization was noted. These findings support the clinical use of two agents used simultaneously, one inhibiting fibrin strand formation and the other inhibiting platelet adherence aggregation, for the prevention of micro-arterial thrombosis.
Insights
Combining anticoagulant and antiplatelet therapies significantly reduces arterial thrombus formation. This synergistic approach, targeting both fibrin and platelets, shows promise for preventing micro-arterial thrombosis.
Area of Science:
- Cardiovascular Research
- Thrombosis Biology
- Pharmacology
Background:
- Arterial intimal injury can lead to thrombus formation.
- Understanding thrombus composition and development is crucial for therapeutic strategies.
Purpose of the Study:
- To investigate the short-term formation and composition of arterial thrombi.
- To evaluate the effects of various antithrombotic agents on thrombus development.
Main Methods:
- Rabbit models of arterial intimal injury.
- Administration of anticoagulants (heparin), antiplatelet agents (aspirin, dextran 40, prostacyclin), and fibrinolytic agents (streptokinase).
- Scanning electron microscopy (SEM) for thrombus surface composition analysis.
Main Results:
- Individual agents demonstrated effects consistent with their known mechanisms.
- Simultaneous administration of agents targeting different thrombogenesis aspects (platelets and fibrin) showed synergistic effects.
- Significant reduction in thrombus accumulation was observed with combined therapy.
- Inhibition of both platelet aggregation and fibrin polymerization was noted.
Conclusions:
- Combined antithrombotic therapy, targeting both fibrin and platelets, offers a synergistic approach to reduce thrombus formation.
- These findings support the clinical use of dual-agent therapy for preventing micro-arterial thrombosis.